The 3rd European Conference on Translational Bioinformatics brings together more than 130 experts

| Published by webs of GRIB, IMIM, UPF

Attendees discussed the recent advances in information technologies that are facilitating translational research and precision medicine.

The 3rd European Conference on Translational Bioinformatics brings together more than 130 experts

The 3rd European Conference on Translational Bioinformatics (ECTB2018) was held on April 16th-17th at the premises of the Barcelona Biomedical Research Park (PRBB) with the attendance of more than 130 European scientists, developers and entrepreneurs, interested in translating genomics and bioinformatics research into healthcare tools and services. The conference aimed to give the participants a unique experience and a forum for discussing fresh scientific results in the translational domain.

The conference brought together world-leading scientists in the area which highlighted on their presentations the recent advances in information technologies that are facilitating translational research and precision medicine. Some of the topics addressed were Big Data integration and analysis, Personalized Medicine, Genome Sequencing initiatives, etc, delivered by scientists from Europe, Canada and the USA. 

It also had a poster session organised to give participants the opportunity to present individual papers and a round table led by Ferran Sanz, co-chair of the event, to discuss about the main challenges that bioinformatics has to overcome, including the opportunities of the industry in this field.

In his closing remarks, Alfonso Valencia, co-chair of the event, expressed gratitude to all who made the event possible and announced that the 4th European Conference on Translational Bioinformatics will take place next year in Sevilla.

The Conference was organized by the Research Programme on Biomedical Informatics (GRIBIMIM-DCEXS-UPF) and the Barcelona Supercomputing Center (BSC). It was supported by the H2020 MedBioinformatics project coordinated by the GRIB and the INB/ELIXIR-ES project.